• 1. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 5. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453

Professional Introduction to Compound with CAS No. 780705-64-8 and Product Name: 1-N-Boc-4-pyriMidin-2-yl-piperazine

1-N-Boc-4-pyriMidin-2-yl-piperazine is a highly specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, identified by the CAS number 780705-64-8, represents a critical intermediate in the synthesis of various bioactive molecules. Its unique structural features, combining a piperazine ring with a pyrimidine moiety, make it a valuable building block for designing novel therapeutic agents. The Boc (tert-butoxycarbonyl) group attached to the nitrogen atom of the piperazine ring enhances its stability and reactivity, making it particularly useful in multi-step synthetic pathways.

The significance of 1-N-Boc-4-pyriMidin-2-yl-piperazine lies in its versatility as a precursor for developing drugs targeting a wide range of diseases. Recent advancements in medicinal chemistry have highlighted its potential in the design of small-molecule inhibitors for enzymes and receptors involved in metabolic disorders, neurodegenerative diseases, and cancer. The pyrimidine ring, a common pharmacophore in many drugs, contributes to the compound's ability to interact with biological targets with high specificity. This interaction is crucial for achieving the desired therapeutic effects while minimizing side reactions.

In the context of drug discovery, 1-N-Boc-4-pyriMidin-2-yl-piperazine has been utilized in the development of compounds that modulate enzyme activity. For instance, researchers have explored its derivatives as potential inhibitors of kinases and phosphodiesterases, which play key roles in cellular signaling pathways. The Boc group on the piperazine ring provides a handle for further functionalization, allowing chemists to introduce additional substituents that enhance binding affinity and selectivity. Such modifications are essential for optimizing drug candidates for clinical trials.

Recent studies have also demonstrated the utility of 1-N-Boc-4-pyriMidin-2-yl-piperazine in the synthesis of compounds with anti-inflammatory properties. The piperazine scaffold is known to exhibit immunomodulatory effects, making it an attractive scaffold for designing drugs that target inflammatory pathways. By incorporating this moiety into larger molecules, researchers have been able to develop novel anti-inflammatory agents that show promise in preclinical models. These findings underscore the importance of 1-N-Boc-4-pyriMidin-2-yl-piperazine as a key intermediate in pharmaceutical innovation.

The compound's structural features also make it suitable for applications in materials science and industrial chemistry. Its ability to form stable complexes with other molecules has led to its use in catalysis and as a ligand in coordination chemistry. Furthermore, its compatibility with various synthetic methodologies makes it a preferred choice for chemists working on complex molecular architectures. This adaptability ensures that 1-N-Boc-4-pyriMidin-2-yl-piperazine remains relevant across multiple disciplines within the chemical industry.

From a regulatory perspective, the synthesis and handling of 1-N-Boc-4-pyriMidin-2-yl-piperazine must adhere to stringent quality control measures to ensure safety and efficacy. Manufacturers must comply with Good Manufacturing Practices (GMP) to guarantee that the final product meets the required specifications for pharmaceutical use. Additionally, researchers must conduct thorough toxicological studies to assess potential hazards associated with the compound. These efforts are critical for ensuring that 1-N-Boc-4-pyriMidin-2-yl-piperazine can be safely integrated into drug development pipelines.

The future prospects of 1-N-Boc-4-pyriMidin-2-yl-piperazine are promising, given its broad applicability and growing body of research supporting its use. As drug discovery continues to evolve, this compound is likely to play an increasingly important role in developing next-generation therapeutics. Collaborative efforts between academia and industry will be essential for maximizing its potential and translating laboratory findings into clinical applications. By leveraging cutting-edge synthetic techniques and computational methods, researchers can further explore the diverse applications of 1-N-Boc-4-pyriMidin-2-yl-piperazine.

In conclusion, 1-N-Boc-4-pyriMidin-2-yl-piperazine (CAS No. 780705-64-8) is a versatile and valuable compound with significant implications for pharmaceutical research and industrial chemistry. Its unique structural properties enable its use as a key intermediate in drug development, particularly for targeting metabolic disorders, neurodegenerative diseases, and cancer. As research progresses, this compound is expected to continue playing a pivotal role in advancing therapeutic innovation across multiple medical fields.

• 501126-08-5(1-Piperazinecarboxylic acid, 4-(5-ethyl-2-pyrimidinyl)-, 1,1-dimethylethylester)
• 1420993-14-1(Tert-Butyl 2-methyl-4-(pyrimidin-2-yl)piperazine-1-carboxylate)
• 1041054-18-5(tert-butyl 4-(4-aminopyrimidin-2-yl)piperazine-1-carboxylate)
• 99931-83-6(4-(2-pyrimidinyl)-1-Piperazinecarboxylic acid ethyl ester)
• 1420963-84-3(Tert-Butyl 3-methyl-4-(pyrimidin-2-yl)piperazine-1-carboxylate)
• 1421015-46-4((S)-Tert-butyl 3-(methyl(pyrimidin-2-yl)amino)pyrrolidine-1-carboxylate)
• 124894-09-3(Tert-Butyl 4-(4,6-dimethylpyrimidin-2-yl)piperazine-1-carboxylate)
• 124863-63-4(Tert-Butyl 4-(4-methylpyrimidin-2-yl)piperazine-1-carboxylate)
• 1272973-58-6(tert-Butyl 4-(5-hydroxypyrimidin-2-yl)piperazine-1-carboxylate)
• 374930-88-8(Tert-butyl 4-(5-bromopyrimidin-2-yl)piperazine-1-carboxylate)